Givaudan, CH0010645932

Givaudan stock slips as Reuters reports a unit review

Published on 08/28/2026 at 06:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan stock eased after Reuters reported a review of the natural ingredients unit on August 27, 2026. The latest market snapshot showed CHF 3,274.00 and a CHF 31.14 billion market cap.

A pop art comic book illustration of a stylised perfume bottle. The unlabelled pink geometric bottle sits at the centre, emanating large swirling fragrance clouds in hot pink and aqua with halftone Ben-Day dot patterns. A yellow sunburst fills the backgro
Givaudan CH0010645932 Pop-Art-Parfumflakon mit Halftone-Punkten, pinken und türkisen Comic-Duftwolken auf gelbem Hintergrund, Illustration mit AI erstellt.

Givaudan stock (CH0010645932) slipped to CHF 3,274.00 on August 27, 2026, while the market value stood at CHF 31.14 billion and the daily range stretched from CHF 3,241.00 to CHF 3,308.00. Reuters reported on August 27, 2026 that the company is weighing options for its natural ingredients unit, and the move gives investors a fresh operating angle before the next earnings cadence.

Flavours and fragrance mix

The Reuters report said the underperforming portfolio accounts for roughly 7% of flavours sales, while the flavours division itself grew only 0.5% on a like-for-like basis in the first half of 2026. In the same period, the fragrance business grew 6.5% like for like, which underlines where Givaudan's recent momentum has been stronger.

That spread matters because it frames the strategic review as more than a headline event: it is tied to a business mix where one division is moving at 0.5% and another at 6.5% in the first half of 2026. For investors, the key question is whether portfolio changes can close that gap without sacrificing the group’s scale in flavours.

Market and fundamentals

The stock also traded within a 52-week band of CHF 2,566.00 to CHF 3,592.00, leaving the latest quote below the top of that range but well above the low. Yahoo Finance data showed revenue of $7.41 billion and net income attributable to common shareholders of $954 million on a trailing basis, with a profit margin of 12.88%.

That mix gives the move a clear context: a CHF 3,274.00 quote, a CHF 31.14 billion valuation, and a 52-week range that still leaves room above the current level. The trailing revenue base of $7.41 billion and net income of $954 million show the scale behind the shares even as management looks at the natural ingredients unit.

Givaudan's product base

The company’s products span flavors, fragrances, and taste solutions used in food, beverages, personal care, and household goods. That portfolio is the backdrop for the strategic review, because the natural ingredients business sits inside a broader platform that serves both consumer staples and premium brands.

Shares at a glance

As of August 27, 2026, Givaudan traded at CHF 3,274.00, with a market cap of CHF 31.14 billion and a 52-week range of CHF 2,566.00 to CHF 3,592.00. The next reported earnings date was not included in the available data.

Company details

Company: Givaudan SA
ISIN: CH0010645932
Ticker: GIVN
Exchange: SIX Swiss Exchange
Price (as of August 27, 2026, 5:30 p.m. ET): CHF 3,274.00
Market cap: CHF 31.14 billion (as of August 27, 2026)
Sector / Industry: Consumer Staples / Specialty Chemicals
Index membership: SMI

Disclaimer...

en | CH0010645932 | GIVAUDAN | boerse | 70011928 | bgmi